Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Angiomax receives clearance in Canada

Oct. 11, 2002

Factor Xa inhibitors in early development at Boehringer Ingelheim

Oct. 10, 2002

Neutralase phase III protocol submitted

Oct. 9, 2002

Pharmion launches Innohep

Oct. 8, 2002

Bristol-Myers Squibb patent covers novel factor Xa inhibitors

Oct. 7, 2002

Preliminary results on use of argatroban for acute ischemic stroke

Oct. 3, 2002

Clopidogrel approved in E.U. for patients with acute coronary syndrome

Sep. 25, 2002

Novel antiplatelet agents with dual sGC-activating and PDE-inhibitory activity

Sep. 20, 2002

Pilot study for argatroban + tPA in acute ischemic stroke

Sep. 20, 2002

IND filed for rhFXIII in patients with congenital FXIII deficiency

Sep. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...